The Physician Payments Sunshine Act

Slides:



Advertisements
Similar presentations
THE PHYSICIAN PAYMENTS SUNSHINE ACT
Advertisements

Financial Conflict of Interest July 2012 rev
Conflict of Interest (COI) Objectives: Provide an overview of financial conflict of interest (FCOI) related to research activities at Gillette Describe.
1 UMass Dartmouth Conflicts of Interest Policies UMass Dartmouth Liz Rodriguez February 17, 2011.
HIPAA Basics Brian Fleetham Dickinson Wright PLLC.
HIPAA Health Insurance Portability and Accountability Act.
Unified Carrier Registration (UCR) Update August 24, 2006.
Prevent outside interests from adversely affecting professional decision-making, patient care or research objectivity. Prevent outside activities from.
Controlling Off-Label Narcotics Usage - Impact of New Arizona Legislation ARS §
1 Physician-Industry Transparency: The U.S. Physician Payment Sunshine Act.
Sales & Marketing Compliance Training
Congress and Contractor Personal Conflicts of Interest May 21, 2008 Jon Etherton Etherton and Associates, Inc.
Building a Compliance Risk Monitoring Program HCCA Compliance Institute New OrleansApril 19, 2005 Lois Dehls Cornell, Esq. Assistant Vice President, Deputy.
Promoting Objectivity in Research by Managing, Reducing, or Eliminating Conflicts of Interest UT HOP UT HOP The University of Texas at Austin.
Five Activities Contracting Officers and Government Contractors Should Avoid Presented by: James F. Moseley, Jr. of Moseley, Prichard, Parrish, Knight,
Conflict of Interest Michelle Stickler, DEd Office for Research Protections
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
Implementation of Disclosure Legislation in Massachusetts National Disclosure Summit March 6, 2009 Allan Coukell, Director of Policy.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
© 2008 Foley Hoag LLP. All Rights Reserved. 1 The New Massachusetts Pharmaceutical & Medical Device Marketing Regulations How to Address and Overcome Likely.
1 Ethics For the Employee Benefits Agent.  Ethics – defined as a principle of right or good conduct; a system of moral principles or values; the rules.
CONFLICTS OF INTEREST PRESENTED BY THE UMMC OFFICE OF INTEGRITY AND COMPLIANCE.
Will Disclosure Quiet the Industry’s Critics? Peter Lurie, MD, MPH Deputy Director Health Research Group at Public Citizen Presented before The National.
PEO Update 2005 AASCIF Legal Workshop George M. Parham Chief Legal Counsel Idaho State Insurance Fund.
CME Under Fire THOMAS SULLIVAN President Rockpointe Corporation March 6, 2009.
OPEN PAYMENTS UF College of Medicine Brown Bag July 23, 2013 Gary Wimsett, Jr., JD.
Understanding the Forces Driving Disclosure Preconference Session First Annual Summit on Sales & Marketing Disclosure for Drug, Device and Biotech Companies.
+ Conflict of Interest in Physician-Industry Relationships.
Confidentiality for Transportation Personnel  Family Educational Rights and Privacy Act (FERPA)  Kentucky Family Educational Rights and Privacy Act.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
Health Insurance Portability and Accountability Act of 1996 HIPAA Privacy Training for County Employees.
WHAT STAKEHOLDERS NEED TO KNOW ABOUT THE CME/SUNSHINE ACT PROVISION OF THE ‘21 ST CENTURY CURES ACT’ JULY 14,
Fight On Training on NIH Conflict of Interest Rule and Introduction to diSClose Dan Shapiro Director, Research Compliance Ben Bell Manager, Research Compliance.
Rigid Plastic Packaging Container (RPPC) Informational Update Permitting and Compliance Committee Meeting February 17, 2009.
PwC National disclosure audio conference: Analysis of the revised Physician Payments Sunshine Act and state drug marketing laws February 10, 2009 “Where.
The Physician Payments Sunshine Act Legislation Ann Leopold Kaplan October 27, 2008.
Case Studies in the Implementation of a Physician Payment Disclosure Initiative Michael P. Bigelow Assistant General Counsel Eli Lilly and Company.
Presentation Title Speaker Name. Conflict of Interest Disclosures for Speakers 1. I do not have any potential conflicts to disclose. 2. I wish to disclose.
Legal, Regulations, Investigations, and Compliance Chapter 9 Part 2 Pages 1006 to 1022.
AND CE-Prof, Inc. January 28, 2011 The Greater Chicago Dental Academy 1 Copyright CE-Prof, Inc
Disclosure of Financial Interest Policy. Medical Staff Policy Approved by the MEC’s Aimed at protecting the integrity of the LMHS Medical Staffs Requires.
Shedding Some Fair Market Value Light on the Sunshine Act
FDAAA Clinical Trial Disclosure Briefing for GCP/QA SIAC
Washington Update PACT Medical Device Group March 7, 2013 Mark Leahey
What is HIPAA? HIPAA stands for “Health Insurance Portability & Accountability Act” It was an Act of Congress passed into law in HEALTH INSURANCE.
Privacy & Confidentiality
Conflict of Interest Disclosure
Conflict of Interest Disclosure
RxInsider Shannon Staton PharmD Candidate 2016
Analysis of the Proposed Sunshine Rule: Legal Considerations
Conflict of interest disclosure
Washington Update PACT Medical Device Group March 7, 2013 Mark Leahey
Confidential Records and Protected Disclosures
Grant Transparency and Medical Device Companies
Disability Services Agencies Briefing On HIPAA
Disclosures of Potential Conflicts
Continuing Medical Education Commercial Disclosure Requirement
Disclosures of Potential Conflicts
Conflict of Interest Disclosure (over the past 24 months)
Continuing Medical Education Commercial Disclosure Amedco, our CME provider, asks all individual involved in the development and presentation of Continuing.
Lilly Grant Funding Disclosure May 27, 2008
An Introduction to the Sunshine Act
Physician Payments Sunshine Act of 2009 – S. 301
Conflict of Interest Disclosure
CanMEDS Roles Covered X
Conflict of interest disclosure
Conflict of Interest Disclosure
CanMEDS Roles Covered X
Continuing Medical Education Commercial Disclosure Requirement
CanMEDS Roles Covered X
Presentation transcript:

The Physician Payments Sunshine Act 2009 Update: The Physician Payments Sunshine Act

Push for federal disclosure legislation Only a handful of states currently have disclosure requirements, but the number is growing. Companies have to comply with a growing number of state laws and regulations. Of existing requirements, most don’t cover medical device companies, few make information public.

Patients have no definitive resource for information on physician-industry relationships. Medical professionals have limited ways to learn about potential conflicts of thought leaders, article writers, speakers. Research institutions have demonstrated inability to monitor potential conflicts of their employees.

New legislation What must be reported: Name Business address Value of payment Dates of payment Form of payment Nature of payment Product connected to payment, if any

New legislation What must be reported: Payments over $100 annually Differs from prior $500 threshold Physician ownership in nonpublic companies

New legislation Penalties for noncompliance: $1,000 to $10,000, with annual cap of $100,000 Knowing noncompliance: $10,000 to $100,000, with $1,000,000 annual cap.

Preemption “the provisions of this section shall preempt any law or regulation… that requires an applicable manufacturer to disclose or report information regarding a payment or other transfer of value provided by the applicable manufacturer to a covered recipient.” This law “shall not preempt any law… that requires the disclosure or reporting of information not required to be disclosed or reported under this section.”

What is next Currently accepting comments Input, questions always welcome: (202) 224-4515